Catalyst Pharm Inc (CPRX) Stock Price, Quote & News

Company Profile

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well...

Industry: Biotechnology

Sector: Healthcare

Phone: 305 420 3200

Website: catalystpharma.com

Address:

355 Alhambra Circle, Suite 801, Coral Gables, United States

StillWaiting101 Jul. 14 at 7:46 PM

$CPRX XBI is up 1.4% today

1 · Reply

DJS777 Jul. 11 at 1:51 PM

$LFST $CPRX entered both for a swing 👌

1 · Reply

111ggg Jul. 10 at 2:44 PM

$CPRX Nothing like a nice consolidation after a 1 day gain after multiple loss days

1 · Reply

StillWaiting101 Jul. 9 at 8:05 PM

$CPRX ended up outpacing XBI on slightly above average volume, I will take it

0 · Reply

StillWaiting101 Jul. 9 at 5:22 PM

$CPRX XBI being up 3.5% makes this a touch less exciting, but nice to being moving in the right direction for the first time in a while

0 · Reply

ChromeOnTheWheels Jul. 9 at 12:17 AM

$CPRX 🤔🤔🤔

0 · Reply

StillWaiting101 Jul. 8 at 8:04 PM

$CPRX close enough started adding today

1 · Reply

StillWaiting101 Jul. 8 at 6:51 PM

$CPRX come on down a little more, we clearly aren't going up until we tap the trendline, so lets get it over with

0 · Reply

StillWaiting101 Jul. 8 at 3:10 PM

$CPRX looking for $20 to add, so I will be early and start adding at $20.50 and add all the way down

0 · Reply

StillWaiting101 Jul. 8 at 3:08 PM

$CPRX XBI is up 1.7% today

0 · Reply

Top 3 Health Care Stocks You'll Regret Missing This Quarter

MBRX

Jun 11, 2025, 7:08 AM EDT - 4 weeks ago

Strong Inflows Make Catalyst Stock an Outlier

Jun 11, 2025, 7:00 AM EDT - 4 weeks ago

20 stocks you should avoid — no matter how well the market does

CORT CRK CRNC DDD LUMN LYV MGPI

Jun 2, 2025, 8:03 AM EDT - 6 weeks ago

Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer

May 31, 2025, 5:18 AM EDT - 6 weeks ago

Catalyst: Solid Business Model Propels Growth For This Buy And Build Pharma

May 8, 2025, 12:02 PM EDT - 2 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:14 PM EDT - 2 months ago

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update

Apr 30, 2025, 8:03 AM EDT - 2 months ago

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025

Apr 22, 2025, 8:03 AM EDT - 3 months ago

Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025

Apr 8, 2025, 8:06 AM EDT - 3 months ago

Catalyst Pharmaceuticals Announces Health Canada's Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals

Mar 26, 2025, 8:12 AM EDT - 3 months ago

Strong Revenue, Drug Performance Lift Catalyst Shares

Mar 11, 2025, 4:05 AM EDT - 4 months ago

Catalyst Pharmaceuticals: Undervalued Future With Multiple Upside Catalysts

Mar 4, 2025, 8:03 AM EST - 4 months ago

Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference

Mar 3, 2025, 2:39 PM EST - 4 months ago

Catalyst Pharmaceuticals: Stable Firdapse, Promising Agamree, Fycompa Challenges

Feb 27, 2025, 12:29 PM EST - 4 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 4:13 PM EST - 4 months ago

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 12, 2025, 8:03 AM EST - 5 months ago

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

Feb 7, 2025, 3:56 PM EST - 5 months ago

Catalyst Remains a Big Money Favorite

Jan 23, 2025, 8:03 AM EST - 6 months ago

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies

Jan 21, 2025, 8:19 AM EST - 6 months ago

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan

Jan 13, 2025, 8:30 AM EST - 6 months ago

Catalyst Pharmaceuticals: The Stars Align For Flagship FIRDAPSE

Jan 8, 2025, 12:30 PM EST - 6 months ago

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals

Dec 16, 2024, 8:03 AM EST - 7 months ago

Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 25, 2024, 8:03 AM EST - 8 months ago

Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List

Nov 19, 2024, 8:03 AM EST - 8 months ago

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

Nov 13, 2024, 8:03 AM EST - 8 months ago

Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work

Nov 7, 2024, 10:34 AM EST - 8 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 4:12 PM EST - 8 months ago

Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 22, 2024, 8:03 AM EDT - 9 months ago

Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024

Oct 8, 2024, 8:03 AM EDT - 10 months ago

Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts

Oct 1, 2024, 8:03 AM EDT - 10 months ago

Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024

Sep 24, 2024, 6:00 AM EDT - 10 months ago

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan

Sep 12, 2024, 1:00 AM EDT - 10 months ago

Santhera Announces Half-Year 2024 Financial Results and Provides Corporate Update

Aug 14, 2024, 8:35 AM EDT - 11 months ago

Top 3 Health Care Stocks That May Crash In August

CAH VRNA

Aug 8, 2024, 1:30 PM EDT - 1 year ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 4:11 PM EDT - 1 year ago

Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update

Jul 30, 2024, 10:13 AM EDT - 1 year ago

Top 3 Health Care Stocks You May Want To Dump This Quarter

VRDN VRNA

Jul 24, 2024, 8:05 AM EDT - 1 year ago

Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE® in Canada

Jul 22, 2024, 8:03 AM EDT - 1 year ago

Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024

Jul 17, 2024, 11:57 AM EDT - 1 year ago

These small-cap stocks score highest when screened for quality

CALX CARG CORT GOGO MC MYRG PLMR

May 30, 2024, 1:41 PM EDT - 1 year ago

Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®

May 28, 2024, 8:03 AM EDT - 1 year ago

Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024

May 9, 2024, 10:52 AM EDT - 1 year ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:16 PM EDT - 1 year ago

Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update

Apr 25, 2024, 1:00 AM EDT - 1 year ago

Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May

Apr 22, 2024, 8:00 AM EDT - 1 year ago

Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024

Apr 5, 2024, 8:29 PM EDT - 1 year ago

Jim Cramer lays out his top small-cap healthcare picks

ADUS ITGR OMI PGNY

Apr 5, 2024, 6:51 PM EDT - 1 year ago

Jim Cramer recommends five small-cap health-care stocks

ADUS ITGR OMI PGNY

Mar 28, 2024, 8:03 AM EDT - 1 year ago

Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day

Mar 27, 2024, 8:03 AM EDT - 1 year ago

Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium

StillWaiting101 Jul. 14 at 7:46 PM

$CPRX XBI is up 1.4% today

1 · Reply

DJS777 Jul. 11 at 1:51 PM

$LFST $CPRX entered both for a swing 👌

1 · Reply

111ggg Jul. 10 at 2:44 PM

$CPRX Nothing like a nice consolidation after a 1 day gain after multiple loss days

1 · Reply

StillWaiting101 Jul. 9 at 8:05 PM

$CPRX ended up outpacing XBI on slightly above average volume, I will take it

0 · Reply

StillWaiting101 Jul. 9 at 5:22 PM

$CPRX XBI being up 3.5% makes this a touch less exciting, but nice to being moving in the right direction for the first time in a while

0 · Reply

ChromeOnTheWheels Jul. 9 at 12:17 AM

$CPRX 🤔🤔🤔

0 · Reply

StillWaiting101 Jul. 8 at 8:04 PM

$CPRX close enough started adding today

1 · Reply

StillWaiting101 Jul. 8 at 6:51 PM

$CPRX come on down a little more, we clearly aren't going up until we tap the trendline, so lets get it over with

0 · Reply

StillWaiting101 Jul. 8 at 3:10 PM

$CPRX looking for $20 to add, so I will be early and start adding at $20.50 and add all the way down

0 · Reply

StillWaiting101 Jul. 8 at 3:08 PM

$CPRX XBI is up 1.7% today

0 · Reply

send_funds Jul. 8 at 11:33 AM

$CPRX This would usually be a buy for me, but the CEO dumping shares does not fill me with confidence...

0 · Reply

ChromeOnTheWheels Jul. 7 at 11:22 PM

$CPRX Impatient traders. Same story with $LNTH , another gem and long term gainer.

0 · Reply

DougAfter60 Jul. 7 at 7:10 PM

$CPRX

0 · Reply

david999957 Jul. 7 at 7:00 PM

$CPRX This is such an incredible buy now under 21. I'm buying 500 more each nickel down. It boggles my mind who would be selling down here, but thank you.

1 · Reply

111ggg Jul. 7 at 3:35 PM

$CPRX Until CEO SAYS SOMETHING, price goes down. Might not hear until conference call. By then price should be south of 18.

2 · Reply

Dailytraderguy Jul. 4 at 8:58 PM

$CPRX Once the bulls decide the bottom (probably @ or around 20), this stock is one of my favs.

0 · Reply

ChromeOnTheWheels Jul. 3 at 8:50 PM

$LNTH and $CPRX are great longterm holds.

0 · Reply

ChromeOnTheWheels Jul. 3 at 12:05 PM

$CPRX No material weakness in the company. I think people dump when they see a company trade sideways for long enough in search of “quicker” money.

1 · Reply

StillWaiting101 Jul. 2 at 3:52 PM

$CPRX XBI is up 2.3% today

1 · Reply

111ggg Jul. 1 at 8:56 PM

$CPRX According to news on Fidelity, short interest has increased almosr 6% since last qrt report.

1 · Reply

111ggg Jul. 1 at 6:47 PM

$CPRX An other 5 day low.

1 · Reply

david999957 Jun. 30 at 5:12 PM

$CPRX This, $ADMA and $HALO are the 3 strongest buy biotechs currently

1 · Reply

Market Cap	2.66B
Revenue (ttm)	491.73M
Net Income (ttm)	163.89M
EPS (ttm)	N/A
PE Ratio	9.34
Forward PE	10.10
Profit Margin	33.33%
Debt to Equity Ratio	0.00

Volume	633,639
Avg Vol	1,275,542
Day's Range	N/A - N/A
Shares Out	121.98M
Stochastic %K	68%
Beta	0.66
Analysts	Strong Sell
Price Target	$34.00